The actual manufacturing of the company’s Emesyl® product is on schedule to begin August 18, 2014. We are pleased to be able to make these dates available to our shareholders. The completion and release of final product, including Quality Control testing will be September 12, 2014.
"We have been working very closely with Oasis and are pleased that the required lead times to procure packaging and raw product materials have been accurate, ensuring confidence that our timelines are met. We’re fully confident of the final product release date of September 12, and heavy focus is now in place on getting solid distribution orders. It won’t be long before Emesyl® will be available for retail purchase," said Dr. Charles B. Hensley, the inventor of Emesyl® and the Zicam® Cold Remedy.
We are looking forward to these dates being met and distribution to begin for our flagship product Emesyl®, and will be updating shareholders with more information soon.